I joined the Host-Microbe Interactions group for my PhD studies in 2020. Our interest is on the effect that gut microbiome has on the medication that is currently used for Parkinson's Disease. We are applying an interdisciplinary approach, combining experimental and molecular dynamics simulations for better understanding the reaction mechanism of bacterial proteins and how to prevent its interference on the Parkinson's Disease treatment.